Dhampur Bio Organics Limited has released its investor presentation detailing Q3 FY26 financial performance and operational highlights. The leading cane processing company, with nine decades of experience, operates through three strategically located manufacturing facilities in Asmoli, Mansurpur, and Meerganj, focusing on value-added sugar manufacturing and bio-energy production.

Financial Performance Overview

The company's Q3 FY26 results demonstrate mixed performance across business segments. The sugar segment showed remarkable margin improvement despite revenue challenges, while other segments maintained relatively stable operations.

Sugar Segment Performance

The sugar segment delivered significant margin expansion during Q3 FY26:

Sugar production increased to 1,37,654 tons from 1,01,401 tons year-on-year, while average realisation improved to ₹41,316 per ton compared to ₹38,714 per ton in Q3 FY25. Sugar sales volume declined to 73,282 tons from 89,252 tons in the corresponding previous period.

Biofuels & Spirits Segment

The biofuels & spirits segment reported the following performance:

Ethanol production reached 14.45 million BL compared to 15.60 million BL in Q3 FY25, with average realisation at ₹61.99 per BL versus ₹64.02 per BL in the previous year.

Country Liquor Operations

The country liquor segment maintained steady performance with revenue of ₹28.94 crores and EBIT margin of 16.17%. Sales volume reached 11,47,686 cases with average realisation of ₹281.72 per case (net of excise duty).

Manufacturing Capacity and Infrastructure

Dhampur Bio Organics operates comprehensive manufacturing facilities with the following capacities:

The company also produces pharma grade sugar with 700 TPD capacity at the Asmoli plant, approved by Food Safety & Drug Administration authority, and operates domestic spirits production capacity of 8.0 million cases per year.

Nine-Month Performance Highlights

For the nine-month period FY26, the sugar segment achieved revenue of ₹1,319.74 crores with EBIT margin of 2.98%, while biofuels & spirits generated ₹306.22 crores revenue. The country liquor segment contributed ₹86.36 crores with EBIT margin of 15.88%.

Market Position and Strategy

The company continues positioning itself as a value-added sugar manufacturer and bio-energy company, with revenue contribution shifting towards non-sugar segments. The current revenue mix shows 82% from sugar and 18% from non-sugar segments, including biofuels & spirits and country liquor operations. Dhampur Bio Organics maintains its focus on enhancing production of niche, processed and value-added sugar products while moderating exposure to conventional sugar commodity price risks.

Dhampur Bio Organics Limited has delivered a strong financial turnaround in Q3FY26, reporting consolidated net profit of ₹16.90 crores compared to a loss of ₹6.86 crores in the corresponding quarter of the previous year. The company announced these results for the quarter ended December 31, 2025, alongside a strategic partnership exploration for mycoprotein production.

Financial Performance Overview

The company's consolidated financial performance showed significant improvement across key metrics:

The nine-month performance for FY26 showed revenue growth to ₹2,359.82 crores from ₹1,990.24 crores in the corresponding period of FY25, though the company reported a net loss of ₹21.09 crores compared to ₹30.11 crores loss in the previous year.

Segment-wise Performance

The company operates across three main business segments with varying performance:

The sugar segment contributed the highest revenue despite a year-on-year decline, while the country liquor segment showed positive growth. Bio fuels and spirits segment experienced a moderate decline in revenue.

Strategic Partnership Development

Dhampur Bio Organics has entered into a non-binding term sheet with Planetary SA, Switzerland, to explore opportunities for exclusive mycoprotein production and commercialization in India. The arrangement involves using sugar and side streams as feedstock for mycoprotein production.

The company emphasized that this arrangement is subject to execution of definitive agreements and fulfillment of conditions as may be set out in such agreements.

Operational Highlights

Other income for Q3FY26 included insurance claims of ₹8.64 crores, equivalent to losses and expenditures incurred due to breakdowns and accidents during the period. The company maintains consistent accounting policies for such claims.

The implementation of New Labour Codes effective November 21, 2025, led the company to reassess its employee benefit obligations and recognize defined benefit obligations as per actuarial valuation as of December 31, 2025.

Corporate Governance

The Board of Directors meeting was held on January 21, 2026, where directors approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The results were subject to limited review by statutory auditors Mittal Gupta & Co., who expressed an unmodified conclusion.

The company operates with two wholly owned subsidiaries: Sonitron Bio Organics Private Limited and Dhampur International Pte Limited as of December 31, 2025.

Source: Exclusive content